Home

C RUSSELL TRENARY III

CIK 1227307 · CEO AND PRESIDENT · last filed 2024-03-22

C RUSSELL TRENARY III is a CEO AND PRESIDENT who has filed 16 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for OTLK, was dated Mar 22, 2024. Across all open-market trades the lifetime net is +$69.9K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.8K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.8K

Companies

2

Total Filings

16

Lifetime Open-Market Net

$69.9K

Filer Profile

Reported Address
1700 E ST ANDREW PLACE
SANTA ANA, CA 92705
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
OTLK CEO AND PRESIDENT 2,746 $0.67 $1.8K $21.1K 4 2024-03-22
Outlook Therapeutics, Inc. (OTLKW) Delisted CEO and President 35,000 $0.03 $1.1K $48.8K 3 2021-12-06

Recent Filings

16 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-03-22 OTLK Grant (A) — $0 EDGAR
2023-04-19 OTLK Grant (A) — $0 EDGAR
2022-06-23 OTLK Buy (P) +19,925 $21.1K EDGAR
2022-04-04 OTLK Grant (A) — $0 EDGAR
2021-12-06 Outlook Therapeutics, Inc. (OTLKW) Delisted Buy (P) +25,000 $34.8K EDGAR
2021-12-02 Outlook Therapeutics, Inc. (OTLKW) Delisted Buy (P) +10,000 $14.0K EDGAR
2021-07-08 Outlook Therapeutics, Inc. (OTLKW) Delisted Grant (A) — $0 EDGAR
2009-02-27 — Mixed −8,460 -$370.2K
2009-02-26 — Mixed +4,148 -$27.0K
2009-02-26 — Mixed — -$983.5K
Showing 1–10 of 16
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.